Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pinar Kadioglu

Showing results (11-20 of 119) with videos related to

Pageof 12
Sort By:
Neuro Endocrinology Letters|March 26, 2013
Acromegaly is not associated with irritable bowel syndrome: a pilot studyErkan Caglar, Esra Hatipoglu, Mutlu Niyazoglu, et al.
Pituitary|June 8, 2013
Familial acromegaly due to aryl hydrocarbon receptor-interacting protein (AIP) gene mutation in a Turkish cohortMutlu Niyazoglu, Muge Sayitoglu, Sinem Firtina, et al.
Clinics (Sao Paulo, Brazil)|December 29, 2009
Autoantibody frequency in celiac diseaseErkan Caglar, Serdal Ugurlu, Aliye Ozenoglu, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 9, 2020
Efficacy and Safety of Stereotactic Radiotherapy in Cushing's Disease: A Single Center ExperienceTugce Apaydin, Hande Mefkure Ozkaya, Sebnem Memis Durmaz, et al.
Pituitary|December 17, 2013
Impact of treatment satisfaction on quality of life of patients with acromegalyHasan Kepicoglu, Esra Hatipoglu, Irem Bulut, et al.
Neuro Endocrinology Letters|March 26, 2013
Von Hippel Lindau disease with metastatic pancreatic neuroendocrine tumor causing ectopic Cushing's syndromeEsra Hatipoglu, Hasan Kepicoglu, Elif Rusen, et al.
Endocrine|September 13, 2018
Impulse control disorders in patients with prolactinoma receiving dopamine agonist therapy: a prospective study with 1 year follow-upEmir Celik, Hande Mefkure Ozkaya, Burc Cagri Poyraz, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|October 18, 2025
Dynamic changes in IGF-1 levels during cabergoline therapy in prolactinomaAhmet Numan Demir, Alara Birol, Dilan Ozaydin, et al.
Endocrine Journal|May 15, 2007
Forty month follow-up of persistent and difficultly controlled acromegalic patients treated with depot long acting somatostatin analog octreotideDemet Ozgil Yetkin, Serife Nur Boysan, Ozay Tiryakioglu, et al.
Angiology|January 13, 2012
Atherosclerotic risk factors and premature atherosclerosis in acromegaly before and after 48 months of octreotide-LAR treatmentS N Boysan, F Kantarci, O Celik, et al.
Pageof 12

Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
Neuro Endocrinology Letters|March 26, 2013
Acromegaly is not associated with irritable bowel syndrome: a pilot studyErkan Caglar, Esra Hatipoglu, Mutlu Niyazoglu, et al.
Pituitary|June 8, 2013
Familial acromegaly due to aryl hydrocarbon receptor-interacting protein (AIP) gene mutation in a Turkish cohortMutlu Niyazoglu, Muge Sayitoglu, Sinem Firtina, et al.
Clinics (Sao Paulo, Brazil)|December 29, 2009
Autoantibody frequency in celiac diseaseErkan Caglar, Serdal Ugurlu, Aliye Ozenoglu, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 9, 2020
Efficacy and Safety of Stereotactic Radiotherapy in Cushing's Disease: A Single Center ExperienceTugce Apaydin, Hande Mefkure Ozkaya, Sebnem Memis Durmaz, et al.
Pituitary|December 17, 2013
Impact of treatment satisfaction on quality of life of patients with acromegalyHasan Kepicoglu, Esra Hatipoglu, Irem Bulut, et al.
Neuro Endocrinology Letters|March 26, 2013
Von Hippel Lindau disease with metastatic pancreatic neuroendocrine tumor causing ectopic Cushing's syndromeEsra Hatipoglu, Hasan Kepicoglu, Elif Rusen, et al.
Endocrine|September 13, 2018
Impulse control disorders in patients with prolactinoma receiving dopamine agonist therapy: a prospective study with 1 year follow-upEmir Celik, Hande Mefkure Ozkaya, Burc Cagri Poyraz, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|October 18, 2025
Dynamic changes in IGF-1 levels during cabergoline therapy in prolactinomaAhmet Numan Demir, Alara Birol, Dilan Ozaydin, et al.
Endocrine Journal|May 15, 2007
Forty month follow-up of persistent and difficultly controlled acromegalic patients treated with depot long acting somatostatin analog octreotideDemet Ozgil Yetkin, Serife Nur Boysan, Ozay Tiryakioglu, et al.
Angiology|January 13, 2012
Atherosclerotic risk factors and premature atherosclerosis in acromegaly before and after 48 months of octreotide-LAR treatmentS N Boysan, F Kantarci, O Celik, et al.
Pageof 12